Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid

Journal of Microencapsulation

Volumn 28, Issue 7, 2011, Pages 605-613

  Pourshahab, Pejman Sadegh ^a   Gilani, Kambiz ^a   Moazeni, Esmaeil ^a   Eslahi, Hamideh ^a   Fazeli, Mohammad Reza ^a   Jamalifar, Hossein ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aerosols; Microparticles; Nanoparticles; Pulmonary drug delivery

Indexed keywords

CHITOSAN; ISONIAZID; LACTOSE; LEUCINE; MALTODEXTRIN; MANNITOL; NANOPARTICLE; TRIPOLYPHOSPHATE;

AEROSOL; ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SYNTHESIS; GELATION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM INTRACELLULARE AVIUM; PARTICLE SIZE; POWDER; SUSTAINED RELEASE FORMULATION;

ADMINISTRATION, INHALATION; AEROSOLS; ANTITUBERCULAR AGENTS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DRUG CARRIERS; HUMANS; ISONIAZID; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; NANOPARTICLES; PARTICLE SIZE; POLYPHOSPHATES; POWDERS;

EID: 80053415669     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2011.599437     Document Type: Article

References (27)

1. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release, 2004;100:5-28. (Pubitemid 39445982)
2. Aktas Yi, Andrieux K, Alonso MJ, Calvo P, Gursoy RN, Couvreur P, Capan Y. Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor. Int J Pharm, 2005;298:378-83. (Pubitemid 40910746)
3. Azarmi S, Roa WH, Löbenberg R. Targeted delivery of nanoparticles for the treatment of lung diseases. Adv Drug Del Rev, 2008;60:863-75.
4. Bao D, Zhao Y. Building membrane emulsification into pulmonary drug delivery and targeting. Pharm Res, 2010;27:2505-8.
5. Du W-L, Niu S-S, Xu Y-L, Xu Z-R, Fan C-L. Antibacterial activity of chitosan tripolyphosphate nanoparticles loaded with various metal ions. Carbohydr Polym, 2009;75:385-9.
6. Elzatahry AA, Eldin MSM. Preparation and characterization of metronidazoleloaded chitosan nanoparticles for drug delivery application. Polym Adv Technol, 2008;19:1787-91.
7. Gan Q, Wang T, Cochrane C, McCrron P. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B, 2005;44:65-73. (Pubitemid 41111534)
8. Gervelas C, Serandour AL, Geiger S, Grillon G, Fritsch P, Taulelle C, Gall BL, Benech H, Deverre JR, Fattal E, et al. Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: Effect on lung and systemic decorporation of plutonium. J Control Release, 2007;118:78-86. (Pubitemid 46283100)
9. Gilani K, Najafabadi AR, Barghi M, Rafiee-Tehrani M. Aerosolisation of beclomethasone dipropionate using spray dried lactose/polyethylene glycol carriers. Euro J Pharma Biopharm, 2004;58:595-606. (Pubitemid 39297106)
10. Grenha A, Seijo Bn, Remũn'an-Lo'pez C. Microencapsulated chitosan nanoparticles for lung protein delivery. Euro J Pharma Sci, 2005;25:427-37. (Pubitemid 40853870)
11. Helander IM, Miaho-Lassila EL, Ahvenainen R, Rhoades J, Roller S. Chitosan disrupts the barrier properties of the outer membrane of Gram-negative bacteria. Int J Food Microbiol, 2001;71:235-44. (Pubitemid 33123347)
12. Kawashima Y, Handa T, Takenaka H, Lin SY. Novel method for the preparation of controlled-release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphate-chitosan. J Pharma Sci, 1985;74:264-8. (Pubitemid 15105913)
13. Ko JA, Park HJ, Hwang SJ, Park JB, Lee JS. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int J Pharm, 2002;249:165-74. (Pubitemid 35333443)
14. Li HY, Seville PC, Williamson IJ, Birchall JC. The use of amino acids to enhance the aerosolisation of spray-dried owders for pulmonary gene therapy. J Gene Med, 2005;7:343-53. (Pubitemid 40443763)
15. Lo'pez-Leon T, Carvalho ELS, Seijo B, Ortega-Vinuesa JL, Gonza'lez DB. Physicochemical characterization of chitosan nanoparticles: Electrokinetic and stability behavior. J Colloid Interface Sci, 2005;283:344-51. (Pubitemid 40254961)
16. Pan Y, Li Y, Zhao H, Zheng J, Xu H, Wei G, Hao J, Cui F. Bioadhesive polysaccharide in protein delivery system: Chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm, 2002;249:139-47. (Pubitemid 35333440)
17. Pandey R, Khuller GK. Antitubercular inhaled therapy: Opportunities, progress and challenges. Antimicrob Chemother, 2005;55:430-5. (Pubitemid 40542580)
18. Papadimitriou S, Bikiaris D, Avgoustakis K, Karavas E, Georgarakis M. Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydr Polym, 2008;73:44-5.
19. Pilcer G, Amighi K. Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharmaceut, 2010;392:1-19.
20. Rabbani NR, Seville PC. The influence of formulation components on the aerosolisation properties of spray-dried powders. J Control Release, 2005;110:130-40. (Pubitemid 41713937)
21. Shu XZ, Zhu KJ. A novel approach to prepare tripolyphosphate:chitosan complex beads for controlled release drug delivery. Int J Pharm, 2000;201:51-8. (Pubitemid 30364969)
22. Shu XZ, Zhu KJ. Chitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelation. J Microencapsul, 2001;18:237-45. (Pubitemid 32177841)
23. Sung JC, Padilla DJ, Garcia-Contreras L, VerBerkmoes JL, Durbin D, Peloquin CA, Elbert KJ, Hickey AJ, Edwards DA. Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery. Pharm Res, 2009;26:1847-55.
24. Toossi Z, Ellner J, Friedman L, 2001. Tuberculosis: Current concepts and treatment. Boca Raton, Florida, USA: CRC Press.
25. WHO. 2007. Tuberculosis fact sheet in World Health Organization, Geneva.
26. Zahoor A, Sharma S, Khuller GK. Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int J Antimicrob Agents, 2005;26:298-303. (Pubitemid 41338657)
27. Zhou H, Zhang Y, Biggs DL, Manning MC, Randolph HW, Christians U, Hybertson BM, Ng K-Y. Microparticle-based lung delivery of INH decreases INH metabolism and targets alveolar macrophages. J Control Release, 2005;107:288-99. (Pubitemid 41316291)